2020 Clinical Trials Roundup: Disruptions To The Trial Landscape

By Doro Sin, Senior Director, Content Marketing

In this year’s analysis, we dissect data from all Phase I–III clinical trials that started in a year dominated by COVID-19. The report reveals trends, discusses the industry’s evolution, highlights shifts in drug development strategies, and examines the emergence of (or declined activity in) key markets.